Category: Covid-19
-
Epidemiological update: COVID-19 transmission in the EU/EEA, SARS-CoV-2 variants, and public health considerations for Autumn 2023
In recent weeks, signals of SARS-CoV-2 transmission have increased from previously very low levels in the EU/EEA.
-
Communicable disease threats report, 20-26 August 2023, week 34
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 20-26 August and includes updates on avian influenza, botulism, autochthonous dengue, Legionnaires’ disease, COVID-19, West Nile virus, Chikungunya and dengue.
-
Coronavirus disease 2019 (COVID-19) and supply of substances of human origin in the EU/EEA – Third update
This document provides an update on the safety of substances of human origin (SoHO) in relation to COVID-19. It reassesses the risk and proposes revised mitigation measures for preventing transmission through SoHO.
-
Communicable disease threats report, 13-19 August 2023, week 33
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 13-19 August and includes updates on avian influenza A(H5N6), avian influenza A(H9N2), West Nile virus, COVID-19, poliomyelitis, and Crimean-Congo haemorrhagic fever.
-
ECDC classifies XBB.1.5-like lineages with the amino acid change F456L as variants of interest following an increase in SARS-CoV-2 transmission in EU/EEA countries and abroad
In 2023, after several months of very low rates of infection, coronavirus disease 2019 (COVID-19) transmission has started to increase in some EU/EEA countries.
-
Communicable disease threats report, 6 – 12 August 2023, week 32
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 6 – 12 August 2023 and includes updates on measles, COVID-19, swine flu, mpox, diphtheria, West Nile virus, avian influenza, dengue, Crimean-Congo haemorrhagic fever, and invasive meningococcal disease.
-
Work-life balance during the COVID-19 pandemic: ECDC and Eurofound investigate the impact of selected non-pharmaceutical interventions in the EU
The new joint report by ECDC and Eurofound concludes that adult work-life balance was significantly affected by measures such as stay-at-home orders and recommendations.
-
Impact of selected non-pharmaceutical interventions on EU adults’ work-life balance during the COVID-19 pandemic
This report summarises results from an analysis conducted by ECDC and Eurofound to understand the impact of selected NPIs introduced from 2020 to 2022 in response to the COVID-19 pandemic on the WLB among EU adults.
-
Communicable disease threats report, 30 July – 5 August 2023, week 31
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 30 July – 5 August 2023 and includes updates on avian influenza, botulism, echovirus, West Nile virus, COVID-19, and Crimean-Congo haemorrhagic fever.
-
Communicable disease threats report, 23-29 July 2023, week 30
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 23-29 July 2023 and includes updates on cholera, MERS-CoV, Chikungunya, dengue, COVID-19, West Nile virus, avian influenza, echovirus, botulism, and bacterial meningitis.